3′-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression

This publication has 29 references indexed in Scilit:

• Characterization of a novelCYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity
  Human Mutation, 2002
• Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females
  Pharmacogenetics, 2002
• Identification of a Single Nucleotide Polymorphism in the TATA Box of the CYP2A6 Gene: Impairment of Its Promoter Activity
  Biochemical and Biophysical Research Communications, 2001
• Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans
  Clinical Pharmacology & Therapeutics, 2001
• Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4 C
  Pharmacogenetics, 2000
• Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
  Molecular Pharmacology, 2000
• CYP2A6: a human coumarin 7-hydroxylase
  Toxicology, 2000
• Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans
  Clinical Pharmacology & Therapeutics, 2000
• Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism
  FEBS Letters, 1999
• Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population
  FEBS Letters, 1999